|
DEDD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.14840000001271E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06830000004654E-06 |
| Normal-vs-Stage2 |
7.594300E-04 |
| Normal-vs-Stage3 |
1.043220E-04 |
| Normal-vs-Stage4 |
7.972400E-02 |
| Stage1-vs-Stage2 |
6.584600E-01 |
| Stage1-vs-Stage3 |
9.076800E-01 |
| Stage1-vs-Stage4 |
7.423700E-02 |
| Stage2-vs-Stage3 |
7.708000E-01 |
| Stage2-vs-Stage4 |
1.040640E-01 |
| Stage3-vs-Stage4 |
1.213760E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.34120000000659E-06 |
| Normal-vs-AfricanAmerican |
6.598400E-01 |
| Normal-vs-Asian |
2.360400E-02 |
| Caucasian-vs-AfricanAmerican |
3.567800E-02 |
| Caucasian-vs-Asian |
2.055800E-01 |
| AfricanAmerican-vs-Asian |
2.635600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.097710E-02 |
| Normal-vs-Female |
2.62629999969732E-07 |
| Male-vs-Female |
1.863730E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.95409999995222E-06 |
| Normal-vs-Age(41-60Yrs) |
2.32259999999318E-05 |
| Normal-vs-Age(61-80Yrs) |
2.758500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.246030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.003200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.245800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.891200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.985400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.077600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.846800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.419520E-02 |
| Classical-VS-Follicular |
3.561600E-04 |
| Classical-VS-Other |
9.839600E-01 |
| Classical-VS-Normal |
7.662400E-03 |
| Tall-VS-Follicular |
9.566200E-01 |
| Tall-VS-Other |
2.419200E-01 |
| Tall-VS-Normal |
2.44819999999368E-05 |
| Follicular-VS-Other |
2.988800E-01 |
| Follicular-VS-Normal |
6.73740000012302E-07 |
| Other-VS-Normal |
2.434800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.49370000041205E-07 |
| Normal-vs-N1 |
6.606800E-04 |
| N0-vs-N1 |
7.068200E-01 |
|
|
